Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hypertrophy clinical trials
A small indexed set (5 trials) with no open enrollment listed right now.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · none currently recruiting · #3,391 of 28,707 conditions by registered trial count
Hypertrophy: 5 US clinical trials tracked, none currently recruiting.
Hypertrophy is the subject of 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Lindenwood University, running 2 of these trials.
Enrollment posture brief
Registry condition hypertrophy
OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Hypertrophy has no open enrollment in this registry pull (5 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hypertrophy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hypertrophy is recruiting below its size-band peers.
0 of 5 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Hypertrophy research.
Lindenwood University accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Most Hypertrophy trials plan to enrol fewer than 100 people.
Median target enrolment is 30 among the 5 trials that report a genuine target (sentinel values excluded). 5 of those (100%) plan for fewer than 100 participants.
-
Hypertrophy research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Protein Ingestion Timing on Body Composition and Biochemical Markers in Resistance-trained Males
Marymount University
NCT05544955
Dileucine and Resistance Training Adaptations
Lindenwood University
NCT06121869
Egg Consumption and Muscular Adaptations
Alexei Wong
NCT04381390
BFR and Muscle Mitochondrial Oxidative Capacity
Louisiana State University and A&M College
NCT03723226
Effect of Daily Doses of Rice or Whey Protein on Resistance Training Adaptations
Lindenwood University
NCT04411173
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Hypertrophy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hypertrophy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hypertrophy page
5 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Hypertrophy trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Lindenwood University sponsors the most Hypertrophy trials on record, review their full trial history before evaluating a specific study. See Lindenwood University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hypertrophy condition card totals 5 registered trials; most-linked intervention Dileucine; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.